Second-Line Treatment of Advanced Gastric Cancer with Oxaliplatin plus Raltitrexed

Publisher： Karger

E-ISSN： 2296-5262|26|3|255-258

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.3, 2003-07, pp. : 255-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen

By  

Oncology Research and Treatment, Vol. 25, Iss. 4, 2002-09 ,pp. : 358-362

Karger

Access to resources Recommend Favorite

Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 359-365

Karger

Access to resources Recommend Favorite

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study

By  

Oncology Research and Treatment, Vol. 37, Iss. 1-2, 2014-01 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 376-381

Karger

Access to resources Recommend Favorite